Sagimet Biosciences files again for an IPO after releasing NASH data
Two years after filing to go public and then backing out, Sagimet Biosciences has made plans to try again on an IPO.
The California biotech …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
